CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42).

749269-77-0

C17H12F4O2

324.27

UNII-JO8EVV007Q;CHEMBL196246;CHF5022;CHF-5022

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years